{
    "General": {
        "Code": "0VY",
        "Type": "Common Stock",
        "Name": "I-MAB SPONS.ADS/1 -0001",
        "Exchange": "F",
        "CurrencyCode": "EUR",
        "CurrencyName": "Euro",
        "CurrencySymbol": "\u20ac",
        "CountryName": "Germany",
        "CountryISO": "DE",
        "OpenFigi": null,
        "ISIN": "US44975P1030",
        "LEI": "549300L1A5T19703RR64",
        "PrimaryTicker": null,
        "CIK": null,
        "EmployerIdNumber": null,
        "FiscalYearEnd": "December",
        "IPODate": null,
        "InternationalDomestic": null,
        "Sector": "Healthcare",
        "Industry": "Biotechnology",
        "GicSector": "Health Care",
        "GicGroup": "Pharmaceuticals, Biotechnology & Life Sciences",
        "GicIndustry": "Biotechnology",
        "GicSubIndustry": "Biotechnology",
        "Description": "I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting growth hormone, which has completed Phase 3 clinical trials to treat pediatric growth hormone deficiency; Efineptakin alfa, a recombinant human IL-7 that is in Phase 2 for cancer treatment-related lymphopenia and cancer immunotherapy; and Lemzoparlimab, a CD47 monoclonal antibody that has completed Phase 2 clinical trial. Its product candidates also includes TJ210, a monoclonal antibody against human C5aR1 that is in Phase 1 for the treatment of cancers and autoimmune; Uliledlimab, a CD73 antibody, which is in Phase 2 clinical trials for treating solid tumors and oncology; TJ-L14B, a PD-L1-based tumor-dependent T-cell engager for solid cancers; Givastomig, a tumor-dependent T cell engager for gastric and other cancers; TJ-L1IF, a PD-L1/IFN-a antibody-cytokine fusion protein for PD(L)-1 resistant tumors; and TJ-C64B, a bispecific antibody for ovarian and other cancers. The company has strategic collaboration agreement with PT Kalbe Genexine Biologics; AbbVie Ireland Unlimited Company; Jumpcan Pharmaceutical Group; Sinopharm Group Co. Ltd.; and Roche Diagnostics. I-Mab was founded in 2014 and is headquartered in Shanghai, the People's Republic of China.",
        "Address": null,
        "AddressData": null,
        "Listings": {},
        "Officers": {},
        "Phone": null,
        "WebURL": null,
        "LogoURL": "",
        "FullTimeEmployees": 0,
        "UpdatedAt": "2023-08-31"
    },
    "Highlights": {
        "MarketCapitalization": 154809424,
        "MarketCapitalizationMln": 154.8094,
        "EBITDA": -1859417984,
        "PERatio": null,
        "PEGRatio": null,
        "WallStreetTargetPrice": 45.37,
        "BookValue": 29.482,
        "DividendShare": 0,
        "DividendYield": 0,
        "EarningsShare": -3.27,
        "EPSEstimateCurrentYear": 0,
        "EPSEstimateNextYear": 0,
        "EPSEstimateNextQuarter": 0,
        "EPSEstimateCurrentQuarter": 0,
        "MostRecentQuarter": "2023-06-30",
        "ProfitMargin": 0,
        "OperatingMarginTTM": 6.7987,
        "ReturnOnAssetsTTM": -0.2536,
        "ReturnOnEquityTTM": -0.6616,
        "RevenueTTM": -253766000,
        "RevenuePerShareTTM": -3.057,
        "QuarterlyRevenueGrowthYOY": -0.621,
        "GrossProfitTTM": 41594000,
        "DilutedEpsTTM": -3.27,
        "QuarterlyEarningsGrowthYOY": 0
    },
    "Valuation": {
        "TrailingPE": 0,
        "ForwardPE": 0,
        "PriceSalesTTM": 0,
        "PriceBookMRQ": 0,
        "EnterpriseValue": -2731701248,
        "EnterpriseValueRevenue": 0,
        "EnterpriseValueEbitda": 0
    },
    "SharesStats": {
        "SharesOutstanding": 82623296,
        "SharesFloat": 38319559,
        "PercentInsiders": 0.746,
        "PercentInstitutions": 59,
        "SharesShort": null,
        "SharesShortPriorMonth": null,
        "ShortRatio": null,
        "ShortPercentOutstanding": null,
        "ShortPercentFloat": null
    },
    "Technicals": {
        "Beta": 0.9313,
        "52WeekHigh": 6.75,
        "52WeekLow": 1.64,
        "50DayMA": 2.3944,
        "200DayMA": 3.4091,
        "SharesShort": 0,
        "SharesShortPriorMonth": 0,
        "ShortRatio": 0,
        "ShortPercent": 0
    },
    "SplitsDividends": {
        "ForwardAnnualDividendRate": 0,
        "ForwardAnnualDividendYield": 0,
        "PayoutRatio": 0,
        "DividendDate": null,
        "ExDividendDate": null,
        "LastSplitFactor": null,
        "LastSplitDate": null,
        "NumberDividendsByYear": {}
    },
    "Holders": null,
    "InsiderTransactions": {},
    "outstandingShares": {
        "annual": {},
        "quarterly": {}
    },
    "Earnings": {
        "History": {
            "2024-06-30": {
                "reportDate": "2024-08-15",
                "date": "2024-06-30",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": null,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            },
            "2023-12-31": {
                "reportDate": "2024-03-29",
                "date": "2023-12-31",
                "beforeAfterMarket": "BeforeMarket",
                "currency": null,
                "epsActual": null,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            },
            "2023-06-30": {
                "reportDate": "2023-08-17",
                "date": "2023-06-30",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": null,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            }
        },
        "Trend": {
            "2021-12-31": {
                "date": "2021-12-31",
                "period": "+1y",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "13813000.00",
                "revenueEstimateLow": "2800000.00",
                "revenueEstimateHigh": "306500000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "15.00",
                "revenueEstimateGrowth": "-0.9420",
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "-1.4700",
                "epsTrend30daysAgo": "-1.4700",
                "epsTrend60daysAgo": "-1.4700",
                "epsTrend90daysAgo": "-1.4700",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2020-12-31": {
                "date": "2020-12-31",
                "period": "0y",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "236424000.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "215210000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "10.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "0.5700",
                "epsTrend30daysAgo": "0.5700",
                "epsTrend60daysAgo": "0.5700",
                "epsTrend90daysAgo": "0.5700",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "1.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2020-06-30": {
                "date": "2020-06-30",
                "period": "+1q",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "1.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "-0.5300",
                "epsTrend30daysAgo": "-0.5300",
                "epsTrend60daysAgo": "-0.5300",
                "epsTrend90daysAgo": "-0.5300",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2020-03-31": {
                "date": "2020-03-31",
                "period": "0q",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "1.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "-0.5100",
                "epsTrend30daysAgo": "-0.5100",
                "epsTrend60daysAgo": "-0.5100",
                "epsTrend90daysAgo": "-0.5100",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            }
        },
        "Annual": {
            "2023-06-30": {
                "date": "2023-06-30",
                "epsActual": 0
            }
        }
    },
    "Financials": {
        "Balance_Sheet": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Cash_Flow": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Income_Statement": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        }
    }
}